Two negative reports, and I think we can see some rather odd...

Two negative reports, and I think we can see some rather odd statements in both. We know that CS have actively shorted before, thinking that it is on the cards that they are doing it again or I should say have done it again. Let's hope that it is for the last time!
Europe partnership / licence deal would certainly be a catch of the day
Has anyone had a go at a estimate for release sales in the US. I think that there would be about 200 people that require treatment that would be considered on label. 50% take up at 100k = 10 million and thats the first week.
Good luck to all and hold on.